Grupo Medinfar Mergers & Acquisitions

Grupo Medinfar M&A Summary

Grupo Medinfar has acquired 1 company, including 1 in the last 5 years.

Grupo Medinfar’s largest acquisition to date was in 2020, when it acquired Lusomedicamenta Sociedade Técnica Farmacêutica S.A. for $29M. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Grupo Medinfar

Laboratorio Medinfar – Produtos Farmaceuticos, S.A.

Rua Henrique de Paiva Couceiro, 29,
Amadora, 2700-451
Portugal,
+351 21 499 7400
www.medinfar.pt

All (1) Buy (1) Sell (-)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2020-10-01 Lusomedicamenta Sociedade Técnica Farmacêutica, S.A. · Life Science
Jordbro, Sweden

Lusomedicamenta Sociedade Técnica Farmacêutica, S.A. focuses on cardiovascular disease, respiratory diseases and metabolic diseases.

Revenue (mlns) 14 EUR
29
1.9x REVENUE
Divestiture

Grupo Medinfar

Recipharm


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.